Electronic Decision Support Systems for Smokers With Severe Mental Illness
Sponsor: Bristol-Myers Squibb
A NA clinical study on Nicotine Dependence and Schizophrenia, this trial is completed. The trial is conducted by Bristol-Myers Squibb and has accumulated 8 data snapshots since 2011. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2019 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bristol-Myers Squibb
- Dartmouth-Hitchcock Medical Center
- U.S. Department of Education
For direct contact, visit the study record on ClinicalTrials.gov .